会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • PROCESS FOR SYNTHESISING HELIOTROPINE AND ITS DERIVATIVES
    • 合成有机化合物及其衍生物的方法
    • WO2005042512A1
    • 2005-05-12
    • PCT/EP2004/052710
    • 2004-10-28
    • ENDURA S.P.A.BORZATTA, ValerioCAPPARELLA, ElisaGOBBI, CarlottaPOLUZZI, Elisa
    • BORZATTA, ValerioCAPPARELLA, ElisaGOBBI, CarlottaPOLUZZI, Elisa
    • C07D317/54
    • C07D317/54
    • A new high-yield, easily industrialized process for synthesising compounds of formula (IV), in which X 1 and X 2 , the same or different, are linear or branched C1-C8 alkyls, n and m are 0,1 or 2, with the proviso that n and m are not simultaneously 0; or (OX 1 )n and (OX 2 )m taken together form an O-T-O group where T is chosen from -CH 2 -, -CH 2 CH 2­ , -CH 2 CH 2 CH 2 -, -C(CH 3 ) 2 -. The process comprises treating a chloromethyl derivative (I) with an alkaline acetate to form the intermediate acetylderivative (II); the intermediate (II) is to hydrolysed to form the alcohol (III); the alcohol (III) is then oxidised in the presence of air and catalysts to obtain the desired derivative (IV). The process runs its course within a short period of time, with high yields and high selectivity; in addition, the process does not require purification and separation of the intermediates and can therefore be favourably conducted in a single batch.
    • 合成式(IV)化合物的新的高产率,易于工业化的方法,其中X1和X2相同或不同,为直链或支链C1-C8烷基,n和m为0,1或2,其中 条件是n和m不同时为0; 或(OX 1)n和(OX 2)m一起形成O-T-O基团,其中T选自-CH 2 - , - CH 2 CH 2,-CH 2 CH 2 CH 2 - , - C(CH 3)2 - 。 该方法包括用碱性乙酸盐处理氯甲基衍生物(I)以形成中间体乙酰衍生物(II); 中间体(II)被水解形成醇(III); 然后在空气和催化剂的存在下将醇(III)氧化以获得所需的衍生物(IV)。 该过程在短时间内运行,产量高,选择性高; 此外,该方法不需要中间体的纯化和分离,因此可以在单次批次中有利地进行。
    • 6. 发明申请
    • INSECTICIDAL FORMULATIONS OF MICROCAPSULES
    • 微生物的杀虫剂配方
    • WO2014009269A1
    • 2014-01-16
    • PCT/EP2013/064242
    • 2013-07-05
    • ENDURA S.P.A
    • GOBBI, CarlottaCAMPANATI, MatteoBORZATTA, Valerio
    • A01N25/04A01N25/28A01N31/14A01N37/38A01N37/44A01N47/40A01N51/00A01N53/00A01N55/00A01P7/04
    • A01N53/00A01N25/00A01N25/04A01N43/30A01N43/50A01N51/00A01N25/28
    • Use of formulations consisting of suspo-emuls ions comprising a microcapsule suspension, the microcapsules including at least one active ingredient selected from the pyrethroid and/or neonicotinoid classes, at least one synergistic agent, and an emulsion comprising at least an active ingredient of the above classes, and at least one synergistic agent, the microcapsules being formed of polyurea, obtainable by inter- facial polymerization of diphenylmethylen - 4, 4 ' -diisocyanate, optionally in admixture with polymethylenpolyphenylisocyanate, the formulations having a prolonged knockdown and killing effect, even of three months, even of six months or even of nine months, the suspo-emulsions comprising: component A) : microcapsules in suspension comprising inside the microcapsule at least one active ingredient, a synergistic agent, optionally a solvent, the total amount of these components being not higher than 50% by weight with respect to the weight of the suspension A), the complement to 100% by weight of component A) comprising the polymer of the micro-capsule shell, water and additives; component B) : emulsion comprising an amount of at least one active ingredient and one synergistic agent, the amount of active ingredient + synergistic agent being not higher than 50% by weight of the emulsion, of component B) constituted by water, additives, optionally solvents.
    • 包含由包含微胶囊悬浮液的悬浮乳液离子组成的制剂的使用,所述微胶囊包括至少一种选自拟除虫菊酯和/或新烟碱类的活性成分,至少一种协同剂,和至少包含上述活性成分的乳液 类别和至少一种协同剂,微胶囊由聚脲形成,可通过二苯基亚甲基-4,4'-二异氰酸酯的面间聚合获得,任选与聚亚甲基聚苯基异氰酸酯混合,该制剂具有延长的杀伤和杀伤作用,甚至是 三个月甚至六个月甚至九个月的悬浮乳液,包含:组分A):悬浮液中的微胶囊,其包含至少一种活性成分,协同剂,任选的溶剂,微胶囊内的这些组分的总量 相对于悬浮液A)的重量,不高于50重量%,补体 至100重量%的组分A),其包含微胶囊壳的聚合物,水和添加剂; 组分B):包含一定量的至少一种活性成分和一种协同剂的乳液,活性成分+协同剂的量不超过乳液的50重量%,组分B)由水,添加剂,任选地 溶剂。